MONDAY, March, 2, 2026 — The U.S. Food and Drug Administration’s (FDA) chief says the agency will begin offering bonuses to drug reviewers who complete their work ahead of schedule.
Dr. Marty Makary described the effort as a pilot…
Blog
Leave a Reply